Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06554067 Effects of tDCS and VNS on Postoperative Analgesia |
Active transcranial direct curren… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Columbia University | Non communiqué | 2024-08 → 2026-08 | Ouvrir |
| NCT06923007 Advant — Alzheimer's Disease Treated With Vagus Nerve Stimulation |
Vagus nerve stimulation | SEP | Non applicable | RECRUITING | En attente / non publié | Stanford University | China · Beijing Tiantan Hospital, Beijing, China | 2025-05-07 → 2027-12 | Ouvrir |
| NCT04437498 VNS mTBI — Vagal Nerve Stimulation in mTBI |
sham stimulation | SEP | Non applicable | RECRUITING | En attente / non publié | German Diabetes Center | United States · Atlanta VA Medical and Rehab Center, … | 2021-02-25 → 2026-12-10 | Ouvrir |
| NCT07371676 Effects of Vagus Nerve Stimulation on the Autonomic Nervous System |
Stimulation | SEP | Non applicable | COMPLETED | En attente / non publié | Istanbul Gelisim University | Turkey (Türkiye) · Istanbul Gelisim University, Istan… | 2024-09-17 → 2025-12-05 | Ouvrir |
| NCT05417711 Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-M… |
Transcutaneous Vagus Nerve Stimul… | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Sun Yat-Sen Memorial Hospital of … | Non communiqué | 2023-11-23 → 2026-09-01 | Ouvrir |
| NCT05801809 Understanding the Effects of Transauricular Vagus Nerve Stimulation on … |
Transauricular vagus nerve stimul… | SEP | Non applicable | COMPLETED | En attente / non publié | Spaulding Rehabilitation Hospital | United States · Spaulding Hospital Cambridge, Cambrid… | 2023-04-26 → 2026-03-01 | Ouvrir |
| NCT06280755 RECLAIM — Clinical Impact Through AI-assisted MS Care - A Retrospective… |
RECLAIM — Clinical Impact Through… | SEP | À vérifier | RECRUITING | En attente / non publié | icometrix | Czechia, Germany · ERC Charité - Universitätsmedizin … | 2024-03-01 → 2027-04 | Ouvrir |
| NCT00283023 Oligodendrocyte Progenitor Cell Culture From Human Brain |
Oligodendrocyte progenitor cell c… | SEP | Phase 1 | COMPLETED | En attente / non publié | Department of Medical Services Mi… | Thailand · Assistant Professor Subsai Kongsaengdao, B… | 2007-12 → 2010-12 | Ouvrir |
| NCT07479212 MOGHEAD — Headache Prevalence and Phenotype in Myelin Oligodendrocyte G… |
MOGHEAD — Headache Prevalence and… | SEP | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Fondazione Policlinico Universita… | Non communiqué | 2026-03-31 → 2026-12 | Ouvrir |
| NCT05154370 CNRID — China National Registry of Neuro-Inflammatory Diseases |
Intravenous steroid | SEP | À vérifier | RECRUITING | En attente / non publié | Beijing Tiantan Hospital | China · Beijing Tiantan Hospital, Beijing, China | 2021-12-15 → 2026-11-01 | Ouvrir |
| NCT04838886 The Effect of Telerehabilitation Based Pilates Training in Multiple Scl… |
The Effect of Telerehabilitation … | SEP | Non applicable | COMPLETED | En attente / non publié | Gazi University | Turkey (Türkiye) · Gazi University, Faculty of Health… | 2021-04-15 → 2022-05-25 | Ouvrir |
| NCT00001669 A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II P… |
rhIGF-1 (CEP-151) | SEP | Phase 2 | COMPLETED | En attente / non publié | National Institute of Neurologica… | United States · National Institute of Neurological Di… | 1997-07 → 2000-04 | Ouvrir |
| NCT04201470 AMIS — Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis |
AMIS — Serum Neurofilaments and G… | SEP | Non applicable | COMPLETED | En attente / non publié | University Hospital, Montpellier | France · CHU Montpellier, Montpellier, France | 2019-12-09 → 2022-05-23 | Ouvrir |
| NCT04561557 CARTinNS — Safety and Efficacy of CT103A Cells for Relapsed/Refractory … |
CT103A cells | SEP | Phase 1 | RECRUITING | En attente / non publié | Tongji Hospital | China · Tongji Hospital affiliated to Tongji Medical … | 2020-09-22 → 2027-05-31 | Ouvrir |
| NCT05147532 SMARTinMS — Remyelination in Multiple Sclerosis: a PET-MR Longitudinal … |
PET-MRI with [18F]-Florbetaben an… | SEP | Non applicable | UNKNOWN | En attente / non publié | Assistance Publique - Hôpitaux de… | France · CIC Neurosciences - Hôpital Pitié Salpêtrièr… | 2022-01-24 → 2024-05 | Ouvrir |
| NCT04539002 Aerobic Exercise for Remyelination in Multiple Sclerosis |
Aerobic Exercise for Remyelinatio… | SEP | Phase 1/2 | COMPLETED | En attente / non publié | Oregon Health and Science Univers… | United States · Oregon Health & Science University, P… | 2021-04-29 → 2025-03-27 | Ouvrir |
| NCT06065670 ReINFORCE — Assessing Changes in Multi-parametric MRI in Patients With … |
Clemastine Fumarate | SEP | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | University of California, San Fra… | United States · Sandler Neurosciences Building, Neuro… | 2026-09-15 → 2028-10-30 | Ouvrir |
| NCT01772199 Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects W… |
GSK239512 | SEP | Phase 2 | COMPLETED | En attente / non publié | GlaxoSmithKline | Bulgaria, Canada, Czechia, Germany, Spain, Sweden, Uk… | 2013-02 → 2014-09 | Ouvrir |
| NCT05338450 RESTORE — Clemastine Fumarate as Remyelinating Treatment in Internuclea… |
Clemastine Fumarate | SEP | Phase 3 | TERMINATED | En attente / non publié | University of California, San Fra… | Netherlands · Amsterdam UMC, location VUmc, Amsterdam… | 2022-08-30 → 2025-08-15 | Ouvrir |
| NCT01085318 Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Tr… |
Rebif | SEP | Phase 4 | COMPLETED | En attente / non publié | EMD Serono | United States · EMD Serono, Inc., Rockland, United St… | 2010-06-30 → 2012-03-31 | Ouvrir |
| NCT05418010 Natalizumab for the Treatment of People With Inflammatory Demyelination… |
Tyruko Injectable Product | SEP | Phase 2 | RECRUITING | En attente / non publié | Queen Mary University of London | United Kingdom · Royal London Hospital, London, Unite… | 2022-12-01 → 2027-10-31 | Ouvrir |
| NCT01307332 iCAMMS-IST — Advanced MRI Measures of Repair in Alemtuzumab Treated Pat… |
MabCampath-1h | SEP | Phase 3 | COMPLETED | En attente / non publié | University of British Columbia | Canada · University of British Columbia Hospital, Van… | 2011-03 → 2018-09-28 | Ouvrir |
| NCT04767698 Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multip… |
Belimumab | SEP | Phase 2 | TERMINATED | En attente / non publié | Johns Hopkins University | United States · Johns Hopkins University, Baltimore, … | 2021-10-01 → 2022-05-10 | Ouvrir |
| NCT06159712 CoSHEDRMS — Comparative Study of High-Efficacy Disease Modifying Treatm… |
CoSHEDRMS — Comparative Study of … | SEP | Non applicable | UNKNOWN | En attente / non publié | University of Aarhus | Denmark · Aarhus University, Aarhus, Denmark | 2023-11-27 → 2025-11 | Ouvrir |
| NCT04175834 PRECEPT — Comparing Risk and Severity of IRRs in Patients Premedicated … |
cetrizine | SEP | Phase 3 | COMPLETED | En attente / non publié | Providence Health & Services | United States · Providence Neurological Specialties W… | 2020-02-05 → 2022-05-13 | Ouvrir |